Yüklüyor......

Toxicity‐dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials

Phase I trials of anti‐cancer therapies aim to identify a maximum tolerated dose (MTD), defined as the dose that causes unacceptable toxicity in a target proportion of patients. Both rule‐based and model‐based methods have been proposed for MTD recommendation. The escalation with overdose control (E...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Stat Med
Asıl Yazarlar: Wheeler, Graham M., Sweeting, Michael J., Mander, Adrian P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5462100/
https://ncbi.nlm.nih.gov/pubmed/28295513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.7280
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!